Akouos Inc. Made Headway
Mon, Jan 24, 2022 at 05:30 PM
Akouos Inc. (AKUS:NASDAQ) rocketted at $6.66, representing a gain of 19.1%. On Fri, Jan 21, 2022, AKUS:NASDAQ hit a New 2-Week Low of $5.59. The stock got featured on our News Catalysts scanner on Fri, Jan 07, 2022 at 09:38 AM in the 'MISCELLANEOUS' category. From Mon, Jan 10, 2022, the stock recorded 12.50% Up Days and 33.33% Green Days
About Akouos Inc. (AKUS:NASDAQ)
Akouos Inc is a genetic medicine company focused on developing gene therapies that restore, improve, and preserve hearing.
Top 10 Gainers:
- Exterran Corporation (EXTN:NYSE), 59.67%
- ShiftPixy, Inc. (PIXY:NASDAQ), 38.71%
- Kohl's Corporation (KSS:NYSE), 36.02%
- Greenwich LifeSciences Inc (GLSI:NASDAQ), 26.99%
- Sweetgreen Inc. Class A (SG:NYSE), 23.34%
- Gelesis Holdings Inc. (GLS:NYSE), 22.37%
- Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ), 21.25%
- Atlas Technical Consultants, Inc. (ATCX:NASDAQ), 20.13%
- Immunome Inc. (IMNM:NASDAQ), 19.46%
- Akouos Inc. (AKUS:NASDAQ), 19.14%